Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation

被引:83
作者
Hughes, Martina M. [2 ,6 ,7 ]
Carballedo, Angela [3 ,4 ,5 ]
McLoughlin, Declan K. [6 ,7 ]
Amico, Francesco [3 ,4 ,5 ]
Harkin, Andrew [8 ]
Frodl, Thomas [3 ,4 ,5 ]
Connor, Thomas J. [1 ,2 ]
机构
[1] Trinity Coll Dublin, Lloyd Inst, Inst Neurosci, Dublin 2, Ireland
[2] Sch Med, Dept Physiol, Neuroimmunol Res Grp, Dublin 2, Ireland
[3] Univ Dublin, Trinity Coll, Dept Psychiat, Dublin, Ireland
[4] Univ Dublin, Trinity Coll, Inst Neurosci, Natl Childrens Hosp, Dublin, Ireland
[5] Univ Dublin, Trinity Coll, St Jamess Hosp, Dublin, Ireland
[6] St Patricks Univ Hosp, Trinity Coll Dublin, Dept Psychiat, Dublin 8, Ireland
[7] St Patricks Univ Hosp, Trinity Coll Dublin, Inst Neurosci, Trinity Coll, Dublin 8, Ireland
[8] Sch Pharm & Pharmaceut Sci, Neuropsychopharmacol Res Grp, Dublin 2, Ireland
基金
爱尔兰科学基金会;
关键词
Kynurenine; IDO; Cytokine; Inflammation; IFN-gamma; IL-6; IL-1; TNF-alpha; SERT; Depression; C-REACTIVE PROTEIN; INTERFERON-ALPHA; INDOLEAMINE 2,3-DIOXYGENASE; CANCER-PATIENTS; SEROTONIN TRANSPORTER; IMMUNE ACTIVATION; SERUM TRYPTOPHAN; INFLAMMATION; ASSOCIATION; SYMPTOMS;
D O I
10.1016/j.bbi.2012.05.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The kynurenine pathway (KP) and its rate-limiting tryptophan degrading enzyme indolamine 2,3-dioxygenase (IDO) have been implicated in the pathogenesis of depression. IDO expression is driven by inflammatory cytokines, and has been suggested as the link between inflammation and a serotonergic deficit in depression. Studies also indicate that inflammatory cytokines upregulate the serotonin transporter (SERT), representing another mechanism by which inflammation could influence serotonin availability. Here we examined circulating concentrations of inflammatory cytokines (IFN-gamma, TNF-alpha, IL-1 beta, IL-6), and the acute phase protein CRP alongside plasma tryptophan, kynurenine, kynurenic acid (KYNA) and 3-hydroxyanthranilic acid (3-HAA) concentrations, and whole blood mRNA expression of IDO, kynurenine aminotransferases (KAT I and II), kynurenine-3-monooxygenase (KMO), kynureninase and SERT in patients with major depressive disorder (MDD) compared with age and sex-matched controls. Whilst no changes in TNF-alpha or IL-1 beta were observed, plasma concentrations of IL-6, 1FN-gamma and CRP were increased in the depressed cohort. Despite this inflammatory phenotype, IDO expression or plasma kynurenine were not significantly different between MDD patients and controls. In addition, there was no difference between controls and depressives in concentrations of KYNA and 3-HAA, or in expression of enzymes KAT, KM or kynureninase that drive their production. Nonetheless, a depletion in tryptophan was evident in depressed patients and was correlated with HAM-D scores. In addition, we failed to observe any difference in SERT mRNA expression in the blood cells from patients with MDD relative to controls. These data support the idea that a mild inflammatory signature is evident in MDD and is accompanied by reduced circulating tryptophan concentrations. However, we found no indication of KP activation in the depressed cohort suggesting that an alternative mechanism mediates the depletion of tryptophan observed. Taken together these data question the ability of the mild inflammatory phenotype observed in depression to induce molecules such as IDO and SERT that could negatively impact upon serotonergic functioning. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:979 / 987
页数:9
相关论文
共 54 条
  • [1] Inflaming depression
    Anisman, Hymie
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2011, 36 (05): : 291 - +
  • [2] Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway
    Ball, Helen J.
    Yuasa, Hajime J.
    Austin, Christopher J. D.
    Weiser, Silvia
    Hunt, Nicholas H.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (03) : 467 - 471
  • [3] Benmansour S, 1999, J NEUROSCI, V19, P10494
  • [4] BROWN RR, 1989, CANCER RES, V49, P4941
  • [5] Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy
    Capuron, L
    Ravaud, A
    Dantzer, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) : 2143 - 2151
  • [6] Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy
    Capuron, L
    Raison, CL
    Musselman, DL
    Lawson, DH
    Nemeroff, CB
    Miller, AH
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (07) : 1342 - 1345
  • [7] Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
    Capuron, L
    Ravaud, A
    Neveu, PJ
    Miller, AH
    Maes, M
    Dantzer, R
    [J]. MOLECULAR PSYCHIATRY, 2002, 7 (05) : 468 - 473
  • [8] Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy
    Capuron, L
    Ravaud, A
    Gualde, N
    Bosmans, E
    Dantzer, R
    Maes, M
    Neveu, PJ
    [J]. PSYCHONEUROENDOCRINOLOGY, 2001, 26 (08) : 797 - 808
  • [9] Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
    Capuron, Lucile
    Fornwalt, Fiona B.
    Knight, Bettina T.
    Harvey, Philip D.
    Ninan, Philip T.
    Miller, Andrew H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 119 (1-3) : 181 - 185
  • [10] INTERFERON-INDUCED INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY IN HUMAN MONONUCLEAR PHAGOCYTES
    CARLIN, JM
    BORDEN, EC
    SONDEL, PM
    BYRNE, GI
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 45 (01) : 29 - 34